✦ LIBER ✦

Targeted therapy for colorectal cancer resistance to EGF receptor antibodies and new trends

✍ Scribed by Katsios, Christos; Ziogas, Demosthenes E; Roukos, Dimitrios H; Baltogiannis, George

Book ID: 120214867
Publisher: Expert Reviews
Year: 2013
Tongue: English
Weight: 679 KB
Volume: 7
Category: Article
ISSN: 1747-4124
DOI: 10.1586/egh.12.60

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

638 Acquired resistance to EGF receptor-

638 Acquired resistance to EGF receptor-targeted cancer therapy

✍ Y. Lu; R. Luwor; K. Liang; X. Li; G. Mills; J. Mendelsohn; Z. Fan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 284 KB

Targeting mechanisms of resistance to an

Targeting mechanisms of resistance to anti-EGF receptor therapy in KRAS wild-type colorectal cancer: the path to more personalized medicine

✍ Fakih, Marwan 📂 Article 📅 2013 🏛 Future Medicine 🌐 English ⚖ 452 KB

Targeted Therapy of Cancer: New Prospect

Targeted Therapy of Cancer: New Prospects for Antibodies and Immunoconjugates

✍ Dr. Robert M. Sharkey; Dr. David M. Goldenberg 📂 Article 📅 2006 🏛 American Cancer Society 🌐 English ⚖ 659 KB

Monoclonal antibodies to target epiderma

Monoclonal antibodies to target epidermal growth factor receptor–positive tumors : A new paradigm for cancer therapy

✍ Roy S. Herbst; Dong M. Shin 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

PIK3CA Mutations in Colorectal Cancer Ar

PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies

✍ Sartore-Bianchi, Andrea (author);Martini, Miriam (author);Molinari, Francesca (a 📂 Article 📅 2009 🏛 American Association for Cancer Research 🌐 English ⚖ 431 KB

PIK3CA Mutations in Colorectal Cancer Ar

PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies

✍ Sartore-Bianchi, Andrea (author);Martini, Miriam (author);Molinari, Francesca (a 📂 Article 📅 2009 🏛 American Association for Cancer Research 🌐 English ⚖ 431 KB